SEC 13F Intelligence

Medicxi Ventures Management (Jersey) Ltd / PHAT

Medicxi Ventures Management (Jersey) Ltd’s Phathom Pharmaceuticals Inc Position

Does Medicxi Ventures Management (Jersey) Ltd own Phathom Pharmaceuticals Inc (PHAT)? Yes — 7.46M shares worth $83M (+8.45% of its 13F portfolio) as of Q1 2026.

Position Value
$83M
Q1 2026
Shares
7.46M
% of Portfolio
+8.45%
Quarters Held
26
currently held

Position History PHAT

Reported value by quarter
Q4 ’19: $64MQ4 ’19Q1 ’20: $53MQ2 ’20: $68MQ3 ’20: $76MQ4 ’20: $69MQ4 ’20Q1 ’21: $78MQ2 ’21: $70MQ3 ’21: $66MQ4 ’21: $41MQ4 ’21Q1 ’22: $28MQ2 ’22: $21MQ3 ’22: $28MQ4 ’22: $28MQ4 ’22Q1 ’23: $18MQ2 ’23: $54MQ3 ’23: $39MQ4 ’23: $34MQ4 ’23Q1 ’24: $79MQ2 ’24: $77MQ3 ’24: $135MQ4 ’24: $61MQ4 ’24Q1 ’25: $47MQ2 ’25: $72MQ3 ’25: $88MQ4 ’25: $124MQ4 ’25Q1 ’26: $83Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20267.46M$83M+8.45%
Q4 20257.46M$124M+14.83%
Q3 20257.46M$88M+11.80%
Q2 20257.46M$72M+16.75%
Q1 20257.46M$47M+10.69%
Q4 20247.46M$61M+11.46%
Q3 20247.46M$135M+25.52%
Q2 20247.46M$77M+22.93%
Q1 20247.46M$79M+17.65%
Q4 20233.76M$34M+11.59%
Q3 20233.76M$39M+12.45%
Q2 20233.76M$54M+15.09%
Q1 20232.48M$18M+7.60%
Q4 20222.48M$28M+11.71%
Q3 20222.48M$28M+11.46%
Q2 20222.45M$21M+8.59%
Q1 20222.07M$28M+7.62%
Q4 20212.07M$41M+10.18%
Q3 20212.07M$66M+14.44%
Q2 20212.07M$70M+12.54%
Q1 20212.07M$78M+45.23%
Q4 20202.07M$69M+39.92%
Q3 20202.07M$76M+36.21%
Q2 20202.07M$68M+41.83%
Q1 20202.07M$53M+69.76%
Q4 20192.07M$64M+39.46%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Medicxi Ventures Management (Jersey) Ltd’s full portfolio or all institutional holders of PHAT.